ADVANTAGE INVESTMENT MANAGEMENT, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
ADVANTAGE INVESTMENT MANAGEMENT, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2019$59,000
-29.8%
512
+5.1%
0.05%
-28.1%
Q2 2019$84,000
+2.4%
4870.0%0.06%0.0%
Q1 2019$82,000
+49.1%
487
-13.3%
0.06%
+52.4%
Q4 2018$55,000
-43.3%
5620.0%0.04%
-33.3%
Q3 2018$97,000
+26.0%
562
+2.2%
0.06%
+12.5%
Q2 2018$77,000
+120.0%
550
+77.4%
0.06%
+330.8%
Q1 2018$35,000
-12.5%
310
+3.3%
0.01%
+8.3%
Q4 2017$40,000
+700.0%
300
+500.0%
0.01%
+500.0%
Q3 2017$5,0000.0%500.0%0.00%0.0%
Q2 2017$5,000
-16.7%
500.0%0.00%0.0%
Q1 2017$6,0000.0%500.0%0.00%0.0%
Q4 2016$6,000
-14.3%
500.0%0.00%
-33.3%
Q3 2016$7,000
-22.2%
50
-50.0%
0.00%
-25.0%
Q2 2016$9,000
-59.1%
100
-66.7%
0.00%
-55.6%
Q1 2016$22,000
+4.8%
3000.0%0.01%
-18.2%
Q4 2015$21,000
+16.7%
300
+50.0%
0.01%
+10.0%
Q3 2015$18,000
-28.0%
2000.0%0.01%
-16.7%
Q2 2015$25,000
+38.9%
2000.0%0.01%
+20.0%
Q1 2015$18,000
-71.0%
200
-78.3%
0.01%
-78.3%
Q4 2014$62,0009230.05%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders